Clinical trial
Personalized Immune Cell Therapy Targeting Neoantigen of Malignant Solid Tumors
NCT05235607 is registered in ClinicalTrials.gov with Sichuan University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Personalized Immune Cell Therapy Targeting Neoantigen of Malignant Solid Tumors
- Lead sponsor
- Sichuan University
- Phase
- Phase 1
- Overall status
- Unknown status
- Start date
- March 1, 2022
- Completion date
- December 2, 2023
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.